New combo pill for blood pressure and cholesterol moves to safety testing

NCT ID NCT07682948

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial studies two experimental drugs, UIC202601 and UIC202602, designed to treat high blood pressure and high cholesterol. It enrolls healthy adults aged 19 to 55 to see how the drugs interact when taken together, focusing on safety and how the body processes them. Participants take one or both drugs daily for a week, and researchers measure drug levels and side effects. The results will guide future studies in patients with these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
UIC202601 and UIC202602
What this could lead to
If successful, this study could help determine safe dosing for a future combination treatment for high blood pressure and high cholesterol.
What could go wrong
This is an early-stage trial in healthy volunteers, not patients, so results may not predict real-world effectiveness or safety in people with these conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Metro Hospital

    RECRUITING

    Anyang, Manan-gu, 14096, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.